CONNECT WITH US
Funding Tracker

Funding Tracker

Oziva spends Rs 246 Cr on marketing for Rs 463 Cr revenue in FY26

Entrackr logo

Published on

Add as a preferred source on Google
Oziva spends Rs 246 Cr on marketing for Rs 463 Cr revenue in FY26

Hindustan Unilever-owned nutrition and wellness brand Oziva recorded strong revenue growth in FY26, months before the FMCG major acquired the remaining 49% stake in the company for Rs 824 crore. However, the growth came at the cost of profitability, as Oziva’s losses widened 4.4X during the year, steered largely by a sharp rise in advertising expenditure.

Oziva’s revenue from operations surged 80% to Rs 463.4 crore in FY26 from Rs 257.8 crore in FY25, according to its financial statements sourced from the Registrar of Companies (RoC).

The company generates revenue from the sale of nutrition and wellness products across categories such as plant-based supplements, protein, vitamins, and products focused on skin and hair health.  These products were the sole source of operating revenue for the company.

Domestic sales remained Oziva’s primary revenue source, contributing Rs 454 crore in FY26, a 77% increase from Rs 257 crore in the previous fiscal year. International sales also increased to Rs 8.3 crore during the year, from just Rs 8.3 lakh in FY25.

Oziva also earned Rs 4.1 crore from non-operating activities, which pushed its total income to Rs 467.5 crore in FY26.

When it comes to spending, advertising and promotional expenditure more than doubled to Rs 246.2 crore in FY26 from Rs 119.8 crore in FY25. This alone accounted for over 51% of the company’s total expenses.

4 crore. 9 crore.



Source link
Related Topics:Funding Tracker

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.